Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-EN | Version v8-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2022-11-18 | 2022-11-18 |
| Drug Identification Number | 02275864 | 02275864 |
| Brand name | HYPURIN NPH INSULIN ISOPHANE PORK | HYPURIN NPH INSULIN ISOPHANE PORK |
| Common or Proper name | Insulin Porcine NPH | Insulin Porcine NPH |
| Company Name | WOCKHARDT UK LIMITED | WOCKHARDT UK LIMITED |
| Ingredients | INSULIN ISOPHANE INJECTION PORK | INSULIN ISOPHANE INJECTION PORK |
| Strength(s) | 100UNIT | 100UNIT |
| Dosage form(s) | SUSPENSION | SUSPENSION |
| Route of administration | SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR | SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR |
| Packaging size | 1 | 1 |
| ATC code | A10AC | A10AC |
| ATC description | INSULINS AND ANALOGUES | INSULINS AND ANALOGUES |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2022-11-15 | 2022-11-15 |
| Estimated end date | ||
| Actual end date | 2022-11-17 | 2022-11-17 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | New batch has been manufactured. Currently awaiting the correct paperwork to facilitate release to market- Paperwork now all in order and goods have been shipped to Canada. | New batch has been manufactured. Currently awaiting the correct paperwork to facilitate release to market- Paperwork now all in order and goods have been shipped to Canada. |
| Health Canada comments |